-
公开(公告)号:FR2889187A1
公开(公告)日:2007-02-02
申请号:FR0508033
申请日:2005-07-28
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , GUILLONNEAU CLAUDE , CHARTON YVES , LOCKHART BRIAN , LESTAGE PIERRE
IPC: C07D213/65 , A61K31/44 , A61P25/00
Abstract: Composés de formule (I) : dans laquelle :n représente un nombre entier compris entre 1 et 6 inclus,R1 et R2 représentent un atome d'hydrogène, un groupement alkyle (C1-C6) ou arylalkyle (C1-C6),R3 et R4 représentent un atome d'hydrogène, un groupement alkyle (C1-C6),R5 et R6 représentent un atome d'hydrogène, un groupement alkyle (C1-C6), halogène, hydroxy, alkoxy (C1-C6), cyano, nitro, acyle (C2-C6), alkoxycarbonyle (C1-C6), trihalogénoalkyle (C1-C6), trihalogénoalkoxy (C1-C6) ou amino éventuellement substitué.Médicaments.
-
公开(公告)号:MXPA06008541A
公开(公告)日:2007-01-29
申请号:MXPA06008541
申请日:2006-07-28
Applicant: SERVIER LAB
Inventor: LESTAGE PIERRE , GOLDSTEIN SOLO , GUILLONNEAU CLAUDE , CHARTON YVES , LOCKHART BRIAN
IPC: A61K31/13 , A61K31/325 , A61K31/44 , A61P25/00 , C07C219/00 , C07D213/74
Abstract: La presente invencion describe compuestos de formula (ver formula (I)) en donde: n represente un entero desde 1 a 6 inclusive; R1 y R2 representan un atomo de hidrogeno, un grupo alquilo de C1-C6 o un grupo aril-alquilo de C1-C6, R3 y R4 representan un atomo de hidrogeno o un grupo alquilo de C1-C6, R5 y R6 representa un atomo de hidrogeno o un grupo alquilo de C1-C6, halogeno, hidroxi, alcoxi de C1-C6, ciano, nitro, acilo de C2-C6, alcoxicarbonilo de C1-C6, trihaloalquilo de C1-C6, trihaloalcoxi de C1-C6, o un grupo amino opcionalmente substituido, R7 representa un atomo de hidrogeno, un grupo alquilo de C1-C6 o un grupo arilalquilo de C1-C6. Medicamentos.
-
公开(公告)号:CA2552831A1
公开(公告)日:2007-01-28
申请号:CA2552831
申请日:2006-07-20
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , LESTAGE PIERRE , CHARTON YVES , LOCKHART BRIAN , GUILLONNEAU CLAUDE
IPC: C07D213/74 , A61K31/44 , A61P25/00
Abstract: Composés de formule (I) : dans laquelle n représente un nombre entier compris entre 1 et 6 inclus, R1 et R2 représentent un atome d'hydrogène, un. groupement alkyle (C1-C6) ou arylalkyle (C1-C6), R3 et R4 représentent un atome d'hydrogène, un groupement alkyle (C1-C6 ), R5 et R6 représentent un atome d'hydrogène, un groupement alkyle (C1-C6), halogène, hydroxy, alkoxy (C1-C6), cyano, nitro, acyle (C2-C6), alkoxycarbonyle (C1-C6 ), trihalogénoalkyle (C1-C6), trihalogénoalkoxy (C1-C6) ou amino éventuellement substitués, R7 représente un atome d'hydrogène, un groupement alkyle (C1-C6) ou arylalkyle. Médicaments.
-
公开(公告)号:CA2555216A1
公开(公告)日:2005-09-29
申请号:CA2555216
申请日:2005-02-18
Applicant: SERVIER LAB
Inventor: LOCKHART BRIAN , CASARA PATRICK , CHOLLET ANNE-MARIE , BERT LIONEL , DHAINAUT ALAIN , LESTAGE PIERRE
IPC: A61K31/403 , A61P25/00 , C07D209/52 , C07D403/12
Abstract: La présente invention concerne les composés de formule (I) : leurs énantiomères, diastéréoisomères, ainsi que leurs sels d~addition à un ou plusieurs acides ou une ou plusieurs bases pharmaceutiquement acceptables. L es composés de la présente invention sont particulièrement intéressant pour leu r interaction avec les systèmes histaminergiques centraux.
-
公开(公告)号:BR0315996A
公开(公告)日:2005-09-27
申请号:BR0315996
申请日:2003-11-04
Applicant: SERVIER LAB
Inventor: RAULT SYLVAIN , LEFLEMME NICOLAS , DALLEMAGNE PATRICK , LESTAGE PIERRE , LOCKHART BRIAN , DANOBER LAURENCE , PFEIFFER BRUNO , RENARD PIERRE
IPC: A61P25/04 , A61P25/28 , C07D211/86 , C07D401/04 , C07D409/04 , A61K31/44
Abstract: 2,3-Dihydro-4(1H)-pyridinone derivatives (I), their enantiomers, diastereoisomers, and acid addition salts are new. 2,3-Dihydro-4(1H)-pyridinone derivatives (I), their enantiomers, diastereoisomers, and acid addition salts are new. R1 = H, 1-6C alkyl, acyl, alkoxycarbonyl, aralkyl aralkoxycarbonyl, or trifluoroacetyl; R2 = 1-6C alkyl; X = O or NOR3; R3 = H, 1-6C alkyl (optionally substituted by OH, amino, alkylamino, dialkylamino and alkoxy); Ar = aryl or heteroaryl where aryl groups may be phenyl, biphenylyl, naphthyl, or tetrahydronaphthyl, all of which are optionally substituted by halogens, alkyl, OH, alkoxy, trihalomethyl, nitro, amino, alkylamino and dialkylamino groups, and heteroaryl groups may be mono or bicyclic and may be substituted by halogens, alkyl, OH, alkoxy, trihalomethyl, nitro, amino, alkylamino and dialkylamino groups.
-
公开(公告)号:EA005185B1
公开(公告)日:2004-12-30
申请号:EA200100597
申请日:2001-06-27
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , GUILLONNEAU CLAUDE , CHARTON YVES , LOCKHART BRIAN , LESTAGE PIERRE
IPC: C07D295/08 , A61K31/10 , A61K31/13 , A61K31/133 , A61K31/15 , A61K31/16 , A61K31/215 , A61K31/22 , A61K31/221 , A61K31/223 , A61K31/27 , A61K31/40 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/445 , A61K31/455 , A61P25/00 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/28 , A61P25/34 , A61P29/00 , A61P29/02 , A61P43/00 , C07C62/02 , C07C209/00 , C07C211/37 , C07C213/00 , C07C213/02 , C07C213/06 , C07C215/20 , C07C215/42 , C07C217/44 , C07C217/52 , C07C219/18 , C07C219/20 , C07C219/24 , C07C269/00 , C07C269/02 , C07C271/12 , C07C271/22 , C07C271/24 , C07C271/34 , C07C319/14 , C07C321/28 , C07C323/26 , C07C323/33 , C07D213/30 , C07D213/38 , C07D213/53 , C07D213/65 , C07D213/70 , C07D213/80 , C07D213/803 , C07D295/096 , C07D417/12
Abstract: Визобретенииописанысоединенияформулы (I)вкоторойр обозначаетцелоечислоот 0 до 6 включительно,n обозначаетцелоечислоот 0 до 6 включительно,Rи Rкаждыйобозначаетгруппу, выбраннуюизатомаводорода, алкильной, арильнойи арилалкильнойгрупп, или R+Rсовместнос азотныматомом, скоторымонисвязаны, образуютнасыщеннуюмоноциклическуюилибициклическуюсистему,X обозначаетгруппу, выбраннуюизатомакислорода, атомасеры, группы -СН=СН-, метилена, группыформулы -HC=N-O- игруппыформулы -О-СН-СН=СН-, причемв соединенияхформулы (I) кислородныйатомэтихгруппсвязанс остатком Y,Y обозначаетгруппу, выбраннуюизарила, гетероарила, арилалкила, гетероарилалкила, -С(О)-Аи -C(S)-A,Аобозначаетгруппу, выбраннуюизалкила, арила, гетероарила, арилалкила, гетероарилалкила, и NRR, гдекаждыйиз Rи Rобозначаетгруппу, выбраннуюизводородногоатома, алкильной, арильнойи арилалкильнойгрупп, или R+Rсовместнос азотныматомом, скоторымонисвязаны, образуютмоноциклическуюилибициклическуюС-Ссистему, ихизомерыи ихаддитивныесолис фармацевтическиприемлемойкислотойилиоснованием; илекарственныесредства.
-
公开(公告)号:AU2003292322A1
公开(公告)日:2004-06-03
申请号:AU2003292322
申请日:2003-11-04
Applicant: SERVIER LAB
Inventor: PFEIFFER BRUNO , RENARD PIERRE , RAULT SYLVAIN , LEFLEMME NICOLAS , DALLEMAGNE PATRICK , LESTAGE PIERRE , LOCKHART BRIAN , DANOBER LAURENCE
IPC: A61P25/04 , A61P25/28 , C07D211/86 , C07D401/04 , C07D409/04 , A61K31/44
Abstract: 2,3-Dihydro-4(1H)-pyridinone derivatives (I), their enantiomers, diastereoisomers, and acid addition salts are new. 2,3-Dihydro-4(1H)-pyridinone derivatives (I), their enantiomers, diastereoisomers, and acid addition salts are new. R1 = H, 1-6C alkyl, acyl, alkoxycarbonyl, aralkyl aralkoxycarbonyl, or trifluoroacetyl; R2 = 1-6C alkyl; X = O or NOR3; R3 = H, 1-6C alkyl (optionally substituted by OH, amino, alkylamino, dialkylamino and alkoxy); Ar = aryl or heteroaryl where aryl groups may be phenyl, biphenylyl, naphthyl, or tetrahydronaphthyl, all of which are optionally substituted by halogens, alkyl, OH, alkoxy, trihalomethyl, nitro, amino, alkylamino and dialkylamino groups, and heteroaryl groups may be mono or bicyclic and may be substituted by halogens, alkyl, OH, alkoxy, trihalomethyl, nitro, amino, alkylamino and dialkylamino groups.
-
公开(公告)号:SI1275647T1
公开(公告)日:2004-02-29
申请号:SI200230005
申请日:2002-07-11
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , POISSONNET GUILLAUME , PARMENTIER JEAN-GILLES , LESTAGE PIERRE , LOCKHART BRIAN
IPC: A61K31/4985 , A61K31/5025 , A61P3/04 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/28 , A61P43/00 , C07D221/00 , C07D241/00 , C07D471/04
Abstract: Octahydro-2H-pyrido(1,2-a) pyrazine derivatives (I), their enantiomers, diastereoisomers, and salts with acids and bases are new. Octahydro-2H-pyrido(1,2-a) pyrazine derivatives of formula (I), their enantiomers, diastereoisomers, and salts with acids and bases are new. Ra = 1-6C alkylene chain; Y = aryl, heteroaryl, or a fused bicyclic ring of formula (a); W1 and W2 = O, S, or NR2; R2 = H, 1-6C alkyl or acyl, aryl, or arylalkyl; R1 = H or 1-6C alkyl; A = a 4-7 membered N heterocycle which is unsaturated or partially saturated (optionally containing a second hetero atom (O, N or S) and optionally substituted by oxo, or 1-6C alkyl); and B = phenyl (optionally substituted by one or more groups selected from halogens, nitro, CN, OH, 1-6C (alkoxy, alkyl, trihaloalkyl, acyl, acyloxy, alkoxycarbonyl or alkylsulfanyl), sulfanyl or amino (optionally substituted by one or two 1-6C alkyl, aryl and 1-6C arylalkyl groups). Provided that: (1) when Y is aryl or heteroaryl, then X is W1, -C(W1)-W2-, -W2-C(W1)-, -W2-C(W1)W2-, -W2-Ra, or -CH(OR1); (2) when Y is a fused bicyclic ring, then X is a simple bond, -C(W1)-, -W2-C(W1)-, -W2-Ra, or -CH(OR1); and (3) compounds 2-octahydro-2H-pyrido(1,2-a)pyrazin-2-yl-1-phenyl ethanol;3-octahydro-2H-pyrido(1,2-a)pyrazin-2-yl propyl-3,4,5-trimethoxy benzoate; and 2-octahydro-2H-pyrido(1,2-a)pyrazin-2-yl ethyl-3,4,5-trimethoxy benzoate are excluded.
-
公开(公告)号:HK1050682A1
公开(公告)日:2003-07-04
申请号:HK03102800
申请日:2003-04-17
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , POISSONNET GUILLAUME , PARMENTIER JEAN-GILLES , LESTAGE PIERRE , LOCKHART BRIAN
IPC: A61K31/4985 , A61K31/5025 , A61P3/04 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/28 , A61P43/00 , C07D221/00 , C07D241/00 , C07D471/04 , C07D , A61K , A61P
Abstract: Octahydro-2H-pyrido(1,2-a) pyrazine derivatives (I), their enantiomers, diastereoisomers, and salts with acids and bases are new. Octahydro-2H-pyrido(1,2-a) pyrazine derivatives of formula (I), their enantiomers, diastereoisomers, and salts with acids and bases are new. Ra = 1-6C alkylene chain; Y = aryl, heteroaryl, or a fused bicyclic ring of formula (a); W1 and W2 = O, S, or NR2; R2 = H, 1-6C alkyl or acyl, aryl, or arylalkyl; R1 = H or 1-6C alkyl; A = a 4-7 membered N heterocycle which is unsaturated or partially saturated (optionally containing a second hetero atom (O, N or S) and optionally substituted by oxo, or 1-6C alkyl); and B = phenyl (optionally substituted by one or more groups selected from halogens, nitro, CN, OH, 1-6C (alkoxy, alkyl, trihaloalkyl, acyl, acyloxy, alkoxycarbonyl or alkylsulfanyl), sulfanyl or amino (optionally substituted by one or two 1-6C alkyl, aryl and 1-6C arylalkyl groups). Provided that: (1) when Y is aryl or heteroaryl, then X is W1, -C(W1)-W2-, -W2-C(W1)-, -W2-C(W1)W2-, -W2-Ra, or -CH(OR1); (2) when Y is a fused bicyclic ring, then X is a simple bond, -C(W1)-, -W2-C(W1)-, -W2-Ra, or -CH(OR1); and (3) compounds 2-octahydro-2H-pyrido(1,2-a)pyrazin-2-yl-1-phenyl ethanol;3-octahydro-2H-pyrido(1,2-a)pyrazin-2-yl propyl-3,4,5-trimethoxy benzoate; and 2-octahydro-2H-pyrido(1,2-a)pyrazin-2-yl ethyl-3,4,5-trimethoxy benzoate are excluded.
-
公开(公告)号:AT236129T
公开(公告)日:2003-04-15
申请号:AT99402624
申请日:1999-10-22
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , DOREY GILBERT , LESTAGE PIERRE , LOCKHART BRIAN
IPC: C07D215/06 , A61K31/47 , A61K31/497 , A61K31/517 , A61P9/10 , A61P25/00 , A61P25/08 , A61P25/16 , A61P25/28 , A61P27/12 , A61P43/00 , C07D215/20 , C07D221/20 , C07D401/06 , C07D471/10 , C07D221/00
Abstract: Dihydro- and tetrahydro-quinoline derivatives (I) are new. Dihydro- and tetrahydro-quinoline derivatives of formula (I) and their acid or base addition salts are new. R1 = H or a group of formula (i); A = H or -B'NZ1Z2; B' = 1-6C alkylene; Z1, Z2 = H, alkyl, 3-8C cycloalkyl or optionally substituted aryl; or NZ1Z2 = heterocycloalkyl or heteroaryl (optionally substituted); R2, R3 = alkyl, 3-8C cycloalkyl, heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl or aminoalkyl (optionally substituted on N with 1 or 2 alkyl, cycloalkyl, aryl or arylalkyl); or R2 + R3 = form with C of quinoline, 3-8C cycloalkyl or heterocycloalkyl (optionally substituted with alkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl); R40 = alkyl, 2-6C alkenyl, 2-6C alkynyl (all optionally substituted), H, Q or -V'-Q; V' = 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene; Q = 3-8C cycloalkyl, aryl, heterocycloalkyl, heteroaryl (all optionally substituted); R5, R41 = H; or R5 + R41 = bond; R6-R9 = H, halo, alkyl, 3-8C cycloalkyl or -OW'; W' = aryl, heteroaryl, arylalkyl, heteroarylalkyl (all optionally substituted), H, alkyl, acyl, 3-8C cycloalkyl or heterocycloalkyl; alkyl = 1-6C; aryl = phenyl, naphthyl or biphenyl; heterocycloalkyl = partially unsaturated 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; heteroaryl = aromatic or partially aromatic 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; substituted aryl, arylalkyl = aryl or arylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted by 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro or OH; substituted alkyl, alkenyl, alkynyl and cycloalkyl = alkyl, alkenyl, alkynyl and cycloalkyl substituted with at least one OH, 1-6C alkoxy, 1-6C alkylthio, amino (optionally substituted with 1 or 2 alkyl), carboxy, nitro, CN, 1-6C alkoxycarbonyl or aminocarbonyl (optionally substituted with 1 or 2 alkyl on N); substituted heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl = heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted with 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro, OH or oxo; and provided that R6-R9 are not all H and at least one of R6-R9 is -OW', that R2 and R3 are alkyl when R6-R9 are H, alkyl, alkoxy, R41 and R5 form a bond, R40 is other than H or alkyl; when (I) has one OH and R40 is other than H; when (I) has one methoxy and R40 is other than hydroxyalkyl; and (I) is other than 7-methoxy-2,2-diphenyl-1,2-dihydroquinoline. An Independent claim is also included for the preparation of (I).
-
-
-
-
-
-
-
-
-